Evidence map›Paper›PMID 39624750›Full record

ArticleSkin health and disease2024

Gender differences in melanoma awareness, diagnosis and treatment: Patient-reported data from a multicentre survey in Switzerland.

Johanna Mangana, Cristina Lamos, Berna C Özdemir, Heinz Läubli, Linda Morgan, Lara V Maul, David König, Florentia Dimitriou, Sandra Kaiser, Janine Landolt and 5 more

Abstract read
In one paragraph

Article in Skin health and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Johanna ManganaDepartment of Dermatology University Hospital Zurich Zurich Switzerland.
Cristina LamosDepartment of Dermatology HFR Fribourg - Cantonal Hospital Villars-sur-Glâne Switzerland.
Berna C ÖzdemirDepartment of Oncology University Hospital Bern Bern Switzerland.
Heinz LäubliDivision of Medical Oncology University Hospital Basel Basel Switzerland.
Linda MorganDepartment of Dermatology University Hospital Zurich Zurich Switzerland.
Lara V MaulDepartment of Dermatology University Hospital of Basel Basel Switzerland.
David KönigDivision of Medical Oncology University Hospital Basel Basel Switzerland.
Florentia DimitriouDepartment of Dermatology University Hospital Zurich Zurich Switzerland.
Sandra KaiserNovartis Pharma Schweiz AG Risch-Rotkreuz Switzerland.
Janine LandoltNovartis Pharma Schweiz AG Risch-Rotkreuz Switzerland.
Anastasia MusiariNovartis Pharma Schweiz AG Risch-Rotkreuz Switzerland.
Nadine PascheNovartis Pharma Schweiz AG Risch-Rotkreuz Switzerland.
Beat SiegenthalerNovartis Pharma Schweiz AG Risch-Rotkreuz Switzerland.
Reinhard DummerDepartment of Dermatology University Hospital Zurich Zurich Switzerland.
Valerio Del PreteDepartment of Dermatology University Hospital Zurich Zurich Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a need to understand the journey of patients with melanoma, including any associated gender differences, to identify aspects in the patient journey that could be improved. We used data collected from an online survey completed by adults with stage III or IV melanoma at three Swiss melanoma centres to understand patients' perceptions of their healthcare journeys from melanoma diagnosis to treatment and the relevance of treatment attributes (Figure 1). We identified that there is a need to improve communication about the testing process and gender differences in terms on information needs, relevance of treatment attributes and attitudes towards psychological support.

Identifiers

PMID39624750
PMCPMC11608883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.